Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Der Nervenarzt|November 6, 2020
[Erratum to: Interdisciplinary neurovascular networks: state of the art]J Röther, O Busse, A Berlis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projectionsAberra Fura, Ashish Khanna, Viral Vyas, et al.
Protein Science : a Publication of the Protein Society|January 30, 2008
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formationWilliam J Metzler, Joseph Yanchunas, Carolyn Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonistsR I Higuchi, J P Edwards, T R Caferro, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2005
Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitorsGuohua Zhao, Prakash C Taunk, David R Magnin, et al.
Nature|March 27, 1997
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsR Mukherjee, P J Davies, D L Crombie, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
The Journal of General Virology|July 29, 2011
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localizationDike Qiu, Julie A Lemm, Donald R O'Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2015
Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophoreJacob J Swidorski, Zheng Liu, Zhiwei Yin, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active siteWei Wang, Pratik Devasthale, Aiying Wang, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Der Nervenarzt|November 6, 2020
[Erratum to: Interdisciplinary neurovascular networks: state of the art]J Röther, O Busse, A Berlis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projectionsAberra Fura, Ashish Khanna, Viral Vyas, et al.
Protein Science : a Publication of the Protein Society|January 30, 2008
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formationWilliam J Metzler, Joseph Yanchunas, Carolyn Weigelt, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonistsR I Higuchi, J P Edwards, T R Caferro, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2005
Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitorsGuohua Zhao, Prakash C Taunk, David R Magnin, et al.
Nature|March 27, 1997
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsR Mukherjee, P J Davies, D L Crombie, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
The Journal of General Virology|July 29, 2011
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localizationDike Qiu, Julie A Lemm, Donald R O'Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2015
Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophoreJacob J Swidorski, Zheng Liu, Zhiwei Yin, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active siteWei Wang, Pratik Devasthale, Aiying Wang, et al.
Pageof 12